The U.S. Food and Drug Administration on Thursday granted traditional approval to the Alzheimer’s drug lecanemab, known by the brand name Leqembi, after an accelerated approval was issued earlier thi… [+4550 chars]Read More
Leqembi first Alzheimers drug to slow disease gets full FDA approval CBS News
